Healthcare · Healthcare Software
Benchling
San Francisco, USA · Series F
Implied valuation
Probability modeled from funding stage, momentum & liquidity signals.
Valuation Trajectory
Funding-round staircase from founding · log scale. Modeled round ladder anchored to the current valuation — illustrative, not a published figure.
IPO Model Drivers
Why the odds read this way
Factor weights are illustrative decompositions of the modeled IPO probability, not guarantees.
Down-Round Risk
Valuation downside pressure
Mixed signals — limited valuation history with 39% modeled IPO odds keep down-round risk in the middle band.
Asset brief
Benchling is a Healthcare · Healthcare Software company last marked at $6.1B. Stage: Series F, $95MM raised to date. No verified market-moving events in the last 30 days.
Benchling is a cloud-based software platform for biotechnology research and development. The company's platform helps scientists to design DNA, collaborate on experiments, and manage research workflows.
Capital Timeline
Funding & liquidity milestones
Series F
$95MM raised · $6.1B